- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Antihypertensives including ACE inhibitors, ARBs help in diabetes prevention
Overview
Diabetes affects about 9% of the adult population worldwide, with a rising prevalence in many regions. In a recent study, researchers of the University of Bristol reported that blood pressure lowering is an effective strategy for the prevention of new-onset type 2 diabetes. They also reported that specific blood pressure-lowering medications reduce the onset risk of diabetes. The study findings were published in the journal The Lancet on November 13, 2021.
Blood pressure-lowering is an established strategy for preventing microvascular and macrovascular complications of diabetes. However, its role in the prevention of diabetes itself is unclear. Therefore, Prof Kazem Rahimi, FRCP and his team conducted a study to examine this question using individual participant data from major randomised controlled trials.
Speakers
Dr. Nandita Mohan
BDS, MDS( Pedodontics and Preventive Dentistry)